PT  - JOURNAL ARTICLE
AU  - Vashist, Kushagra
AU  - Akintobi, Tabia
AU  - Bednarczyk, Robert A.
AU  - Narayan, KM Venkat
AU  - Patel, Shivani A.
TI  - Demographic benchmarks for equitable coverage of the COVID-19 vaccination program among priority populations
AID  - 10.1101/2021.02.18.21251992
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.18.21251992
4099  - http://medrxiv.org/content/early/2021/02/22/2021.02.18.21251992.short
4100  - http://medrxiv.org/content/early/2021/02/22/2021.02.18.21251992.full
AB  - We report the demographic distribution of non-institutionalized populations in the US who are prioritized for COVID-19 vaccination by ethnicity, age and sex and region. The composition of non-institutionalized priority populations was estimated using a nationally representative sample of 25,417 adults interviewed in the National Health Interview Survey (NHIS) in 2018. A relatively large fraction of individuals prioritized for the earliest distribution of the vaccine are women, non-Hispanic Black, and young to middle aged adults. Overall, the study provides a platform to track equity in vaccine coverage and to better tailor health communication strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSAP and KMVN were supported in part by grant number 77624 from the Robert Wood Johnson Foundation. SAP, KMVN, and TA were supported in part by Radx-UP (P30DK111024-05S1). KMVN, TA, and BAB were supported in part by Georgia CEAL (16-312-0217571-66105).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:-All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in the manuscrupt: NHIS 2018 https://www.cdc.gov/nchs/nhis/nhis_2018_data_release.htm